The best stock screener for both US and European stocks in 2026 is ScreenerHero. It covers NYSE, NASDAQ, TSX (Canada), and all major European exchanges — XETRA, Euronext Paris, BME, Borsa Italiana, Euronext Amsterdam, Euronext Brussels, Nasdaq First North, EGM Milan, AIM London, and more — with consistent fundamental filters (P/E, P/B, EV/EBITDA, ROE, margins) that work across all markets. The free tier requires no account. Pro is €29/month.
No other screener at this price covers both US and European markets with reliable fundamental data. The most common alternatives — Finviz (US only) and Stockopedia (Europe, with US added at €80/month) — each require paying for two separate tools to match what ScreenerHero provides in one.
Last updated: July 2026.
The problem: most screeners only cover one market
Investment theses don't respect borders. A value investor looking for cheap industrials should be able to compare a US rail company against a German logistics operator. A dividend investor wants the UK's no-withholding-tax advantage alongside US Dividend Aristocrats. A growth investor screening European software should also see US SaaS comparables.
But the screener market is bifurcated:
US-centric screeners (Finviz, StockRover, Barchart) cover NYSE and NASDAQ comprehensively but have little to no European exchange coverage. Finviz — the most-used US screener — covers US stocks only and has since its founding.
European-centric screeners (Stockopedia, MarketScreener) cover UK and continental European exchanges but have incomplete US coverage, or charge a premium for adding US stocks to a European subscription.
Global screeners that claim multi-market coverage (TIKR, TradingView) technically list stocks from both markets but have inconsistent fundamental data — particularly for European small and mid-caps — making multi-market fundamental comparison unreliable.
The result: an investor covering both US and European markets typically needs two separate tools, pays for both, and cannot run cross-market comparison screens without manually exporting and combining data.
Who needs a cross-market screener?
The pan-Atlantic value investor. US equities trade at ~21× trailing P/E; European equities trade at ~14–15×. A systematic value investor looking for the cheapest businesses globally needs to compare both markets simultaneously — running a screen in only one geography by definition misses the cheapest alternatives in the other.
The dividend income investor. US Dividend Aristocrats (25+ years of consecutive increases) are well-documented. European dividend payers — UK financials with no withholding tax, Spanish utilities with high yields, Nordic industrials with conservative payout ratios — are underrepresented in US-only screeners. A complete dividend screen requires both.
The sector-specialist investor. European industrials (XETRA's Mittelstand), French luxury (CAC 40), Nordic technology (First North), Italian small-cap consumer — these are global sector leaders in their domains. A US-only industrial screen misses KION, Rational, DÜRR, and hundreds of others that dominate their niches.
The GARP investor. Growth at a reasonable price requires comparing valuation (P/E, EV/EBITDA) against growth (revenue CAGR, earnings momentum). Running GARP screens only in the US misses European growth companies — particularly Nordic tech on First North — that often trade at significantly lower multiples than US equivalents with comparable growth profiles.
The Canadian investor. Canadian equities (TSX, TSXV) are structurally undercovered by European screeners and underweighted in US ones. Resource-heavy sectors (mining, energy) and Canadian financials offer genuine diversification and are unavailable on most European-facing tools.
Best screeners for US + European markets compared
1. ScreenerHero — Only dedicated cross-market screener at this price
US coverage: NYSE, NASDAQ, NYSE American, OTC (major listings).
European coverage: XETRA (Germany), Euronext Paris (France), BME (Spain), Borsa Italiana (Italy), Euronext Amsterdam (Netherlands), Euronext Brussels (Belgium), Euronext Lisbon (Portugal), Nasdaq First North Stockholm, Copenhagen, Helsinki, Euronext Growth Paris, EGM Milan, GPW Warsaw, AIM London, SIX Swiss Exchange.
Canadian coverage: TSX (Toronto Stock Exchange), TSXV (TSX Venture Exchange).
Cross-market filter consistency: All fundamental filters — P/E, P/B, EV/EBITDA, ROE, net margin, operating margin, revenue growth, dividend yield, debt/equity — work identically across all markets. You can run a P/E < 12, ROE > 15%, EV/EBITDA < 8 screen and receive results from US, European, and Canadian markets in a single sorted list.
Free tier: Full cross-market screener, no account required.
Paid plan: €29/month Pro. Unlimited results, saved screens, export, alerts.
Best for: Any investor who screens across US and European markets simultaneously. The only tool at this price point with reliable fundamental data across both.
2. Stockopedia — European specialist with US as an add-on
US coverage: Available on the most expensive plan (€80/month). US fundamental data is reasonable for large and mid-caps.
European coverage: Strong for UK (Stockopedia's heritage market). Continental European small caps — Euronext Growth, First North, EGM — have data gaps.
Cross-market filter consistency: Stockopedia's StockRanks composite scores (Quality, Value, Momentum) are calculated separately for each geographic region — so rankings are not directly comparable across US and European markets.
Free tier: None.
Paid plan: €60/month (Europe only) · €80/month (US + Europe).
Best for: Investors who prefer composite scoring over raw filter sliders and are willing to pay a premium for the interface. Not ideal for raw cross-market value comparison.
Price to match ScreenerHero's cross-market capability: €80/month — 2.7× more expensive.
3. TIKR — Broad coverage, inconsistent European fundamentals
US coverage: Good. TIKR Pro covers US large and mid-cap stocks comprehensively.
European coverage: 100,000+ stocks claimed across 92 countries. In practice, fundamental data for European small caps — particularly on alternative markets — is inconsistent. Filter results for EV/EBITDA and P/B on Euronext Growth and First North names are often missing.
Cross-market filter consistency: Inconsistent. US screens are reliable; European small cap screens have significant data gaps.
Free tier: Freemium with friction. Account required.
Paid plan: $40–55/month Pro.
Best for: Deep research on individual companies (especially with historical financial data). Not reliable for systematic cross-market screening of European small caps.
4. Finviz — US benchmark, zero European coverage
US coverage: The best US-focused fundamental screener available. 60+ filters across NYSE, NASDAQ, and OTC.
European coverage: Zero. Finviz covers US markets only. A small number of European ADRs are listed (non-native European exchange listings), but primary European exchange coverage does not exist.
Best for: US-only investors. For cross-market screening, Finviz requires pairing with a separate European screener — doubling the tool cost and losing cross-market comparison.
5. TradingView — Global price data, variable fundamentals
US coverage: Good — price data and technical indicators. Fundamental data for large caps is reliable.
European coverage: Price data is broadly available. Fundamental data for European names below €500M market cap is inconsistent. Alternative market coverage (Euronext Growth, First North, EGM) is particularly variable.
Cross-market filter consistency: Technical filters (RSI, moving averages) work consistently across markets. Fundamental filters (P/E, EV/EBITDA) are unreliable for European small caps.
Free tier: Account required.
Paid plan: $15–60/month.
Best for: Chart-driven investors who want global price data. Not the right tool for systematic cross-market fundamental screening.
Cross-market screener comparison table
| Screener | US Coverage | EU Coverage | EU Small Caps | Canadian | Free No-Account | Price/mo |
|---|---|---|---|---|---|---|
| ScreenerHero | ✓ Full | ✓ Full | ✓ Full | ✓ TSX+TSXV | Yes | €29 |
| Stockopedia | ✓ (€80/mo plan) | ✓ UK strong | Partial | ✗ | No | €60–80 |
| TIKR | ✓ Full | ✓ Listed | Inconsistent | Partial | No | $40–55 |
| TradingView | ✓ Full | ✓ Large cap | Inconsistent | ✓ | No (req. account) | $15–60 |
| Finviz | ✓ Best for US | ✗ | ✗ | ✗ | Yes (US only) | Free / $39.50 |